Search academic texts

Information × Registration Number 0210U001373, 0107U001135 , R & D reports Title Elaboration of pathogenetically founded approaches to treatment of multiple myeloma. popup.stage_title Head Maslyak Zvenyslava Volodymyrivna, Registration Date 10-02-2010 Organization State Institution "Institute of Blood Pathology and Transfusion Medicine AMS Ukraine" popup.description2 The efficiency of the new antimyeloma drugs - Thalidomide and Bortezomib - applied as monotherapy or in combination with chemotherapy agents was analyzed in patients with newly diagnosed Multiple Myeloma or with either resistant to previous therapy or relapsing Multiple Myeloma in comparison with conventional treatment options. Treatment algorithm was developed for Multiple Myeloma patients depending on duration of disease, preceding chemotherapy regimens and eligibility for autologous stem cell transplantation. Combination of the following two parameters - b2-microglobulin and VEGF - may become a new criterion for determination of patient risk groups and for prognosis of Multiple Myeloma course. Product Description popup.authors Виговська Ярослава Іллівна Даниш Ольга Йосипівна Дяків Галина Львівна Кароль Юрій Степанович Книш Наталія Володимирівна Колісник Мар'яна Іванівна Котлярчук Костянтин Богданович Мельник Марія Іллярівна Серафин Наталія Ярославівна Цяпка Орест Миколайович popup.nrat_date 2020-04-02 Close